Free shipping on all orders over $ 500

Hesperadin

Cat. No. M2127

All AbMole products are for research use only, cannot be used for human consumption.

Hesperadin Structure
Size Price Availability Quantity
Free Sample (0.5-1 mg)  USD 0 In stock
10mM*1mL in DMSO USD 65 In stock
2mg USD 33 In stock
5mg USD 60 In stock
10mg USD 90 In stock
Free Delivery on orders over USD 500 Bulk Inquiry?

Quality Control & Documentation
Biological Activity

Hesperadin is an inhibitor of human Aurora B, prevented the phosphorylation of substrate with IC50 of 40 nM. Hesperadin significantly inhibits cell growth of cultured bloodstream forms with IC50 of 50 nM. Hesperadin also inhibits the ability of immunoprecipitated Aurora B to phosphorylate histone H3 with IC50 of 250 nM and markedly reduces the activity of other kinases (AMPK, Lck, MKK1, MAPKAP-K1, CHK1 and PHK) at a concentration of 1 μM. Hesperadin blocked nuclear division and cytokinesis but not other aspects of the cell cycle. Molecular models predicted high-affinity binding of Hesperadin to both conserved and novel sites in TbAUK1. Hesperadin treatment causes defects in mitosis and cytokinesis, leading to stoppage of proliferation of HeLa cells and polyploidization.

Chemical Information
Molecular Weight 516.65
Formula C29H32N4O3S
CAS Number 422513-13-1
Solubility (25°C) DMSO 73 mg/mL
Storage Powder          -20°C   3 years ;  4°C   2 years
In solvent       -80°C   6 months ;  -20°C   1 month
References

[1] Jetton N, et al. Mol Microbiol. The cell cycle as a therapeutic target against Trypanosoma brucei: Hesperadin inhibits Aurora kinase-1 and blocks mitotic progression in bloodstream forms.

[2] Sessa F, et al. Mol Cell. Mechanism of Aurora B activation by INCENP and inhibition by hesperadin.

[3] Hauf S, et al. J Cell Biol. The small molecule Hesperadin reveals a role for Aurora B in correcting kinetochore-microtubule attachment and in maintaining the spindle assembly checkpoint.

Related Aurora Kinase Products
AT9283

AT9283 is a potent inhibitor of several protein kinases, including Aurora A, Aurora B, Janus kinase 2 (JAK2), JAK3, and ABL.

AZD1152-HQPA

AZD1152-HQPA (Barasertib) is a highly potent and selective inhibitor of Aurora with Ki values of 0.36 and 1369 nM for Aurora B and Aurora A respectively.

CCT-129202

CCT129202 is an Aurora kinase inhibitor with IC50 of 0.042 ± 0.022, 0.198 ± 0.05, and 0.227 ± 0.064 μmol/L for Aurora A, Aurora B, and Aurora C, respectively.

CYC116

CYC116 is a potent, small molecule inhibitor of Aurora A, B and C with IC50 value of 44, 19 and 65 nM respectively. CYC-116 also inhibits VEGFR2, Src, Lck AND FLT3 with with Kis of 44, 82, 280, 44 nM, respectively. CYC-116 may have broad-spectrum antitumor activity.

ENMD-2076

ENMD-2076 is an orally-active, Aurora A/angiogenic kinase inhibitor.

  Catalog
Abmole Inhibitor Catalog




Keywords: Hesperadin supplier, Aurora Kinase, inhibitors, activators

All AbMole products are for research use only, cannot be used for human consumption or veterinary use. We do not provide products or services to individuals. Please comply with the intended use and do not use AbMole products for any other purpose.



Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2026 AbMole BioScience. All Rights Reserved.